Pathogenic mechanisms of RAPSN mutations in congenital myasthenic syndromes
Rapsyn is essential for clustering acetylcholine receptors (AChR) at the neuromuscular junction (NMJ). Congenital myasthenic syndrome (CMS) due to RAPSN mutations compromises neuromuscular transmission through a deficiency of AChR at the NMJ. RAPSN-CMS is autosomal recessive, and most patients harbo...
Main Author: | |
---|---|
Other Authors: | |
Published: |
University of Oxford
2015
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.719985 |
id |
ndltd-bl.uk-oai-ethos.bl.uk-719985 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-bl.uk-oai-ethos.bl.uk-7199852018-11-27T03:19:32ZPathogenic mechanisms of RAPSN mutations in congenital myasthenic syndromesCheung, Jonathan YuBeeson, David ; Webster, Richard2015Rapsyn is essential for clustering acetylcholine receptors (AChR) at the neuromuscular junction (NMJ). Congenital myasthenic syndrome (CMS) due to RAPSN mutations compromises neuromuscular transmission through a deficiency of AChR at the NMJ. RAPSN-CMS is autosomal recessive, and most patients harbour a common mutation p.Asn88Lys. A definitive genetic diagnosis for patients who do not carry the p.Asn88Lys allele can be challenging. In this thesis 10 novel variants in RAPSN are shown to impair AChR clustering in vitro, and are thus defined as pathogenic. The properties of RAPSN mutations p.Val45M, p.Asn88Lys, p.Arg91Leu and p.Ala153Thr were studied and were found to be diverse, though common mechanisms were found to underlie the AChR deficiency. The mutations reduce the stability of rapsyn and the stability of AChR-rapsyn clusters formed on cultured myotubes. A unique missense mutation in the AChR d-subunit encoding gene, p.Glu381Lys, phenotypically mimics RAPSN-CMS, and investigations revealed that this mutation also causes instability of the AChR clusters. Salbutamol, a medication that is believed to stabilise NMJ, has recently been found to benefit AChR deficiency patients when used in combination with pyridostigmine. However, the mode of action of salbutamol at the NMJ is undefined. A pilot study was performed to evaluate the efficacy and mechanism of salbutamol therapy in a mouse model of AChR deficiency. Methodologies were established for the analysis of the effects of salbutamol and will provide the basis for a more detailed study of its beneficial action in disorders of neuromuscular transmission.612.8University of Oxfordhttps://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.719985https://ora.ox.ac.uk/objects/uuid:c343ca03-563e-4b4a-9e35-aac09bfc5ea7Electronic Thesis or Dissertation |
collection |
NDLTD |
sources |
NDLTD |
topic |
612.8 |
spellingShingle |
612.8 Cheung, Jonathan Yu Pathogenic mechanisms of RAPSN mutations in congenital myasthenic syndromes |
description |
Rapsyn is essential for clustering acetylcholine receptors (AChR) at the neuromuscular junction (NMJ). Congenital myasthenic syndrome (CMS) due to RAPSN mutations compromises neuromuscular transmission through a deficiency of AChR at the NMJ. RAPSN-CMS is autosomal recessive, and most patients harbour a common mutation p.Asn88Lys. A definitive genetic diagnosis for patients who do not carry the p.Asn88Lys allele can be challenging. In this thesis 10 novel variants in RAPSN are shown to impair AChR clustering in vitro, and are thus defined as pathogenic. The properties of RAPSN mutations p.Val45M, p.Asn88Lys, p.Arg91Leu and p.Ala153Thr were studied and were found to be diverse, though common mechanisms were found to underlie the AChR deficiency. The mutations reduce the stability of rapsyn and the stability of AChR-rapsyn clusters formed on cultured myotubes. A unique missense mutation in the AChR d-subunit encoding gene, p.Glu381Lys, phenotypically mimics RAPSN-CMS, and investigations revealed that this mutation also causes instability of the AChR clusters. Salbutamol, a medication that is believed to stabilise NMJ, has recently been found to benefit AChR deficiency patients when used in combination with pyridostigmine. However, the mode of action of salbutamol at the NMJ is undefined. A pilot study was performed to evaluate the efficacy and mechanism of salbutamol therapy in a mouse model of AChR deficiency. Methodologies were established for the analysis of the effects of salbutamol and will provide the basis for a more detailed study of its beneficial action in disorders of neuromuscular transmission. |
author2 |
Beeson, David ; Webster, Richard |
author_facet |
Beeson, David ; Webster, Richard Cheung, Jonathan Yu |
author |
Cheung, Jonathan Yu |
author_sort |
Cheung, Jonathan Yu |
title |
Pathogenic mechanisms of RAPSN mutations in congenital myasthenic syndromes |
title_short |
Pathogenic mechanisms of RAPSN mutations in congenital myasthenic syndromes |
title_full |
Pathogenic mechanisms of RAPSN mutations in congenital myasthenic syndromes |
title_fullStr |
Pathogenic mechanisms of RAPSN mutations in congenital myasthenic syndromes |
title_full_unstemmed |
Pathogenic mechanisms of RAPSN mutations in congenital myasthenic syndromes |
title_sort |
pathogenic mechanisms of rapsn mutations in congenital myasthenic syndromes |
publisher |
University of Oxford |
publishDate |
2015 |
url |
https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.719985 |
work_keys_str_mv |
AT cheungjonathanyu pathogenicmechanismsofrapsnmutationsincongenitalmyasthenicsyndromes |
_version_ |
1718797294687485952 |